Ad
related to: COVID-19 variants
Search results
Dr. Anthony Fauci says keeping schools shut down for so long amid COVID "was not a good idea"
CBS News· 3 days agoDr. Anthony Fauci is reflecting on some of the actions taken in response to the COVID pandemic,...
We Won't Solve Long COVID Until We Decide What It Is
Medscape· 3 days agoIs a slow recovery from COVID-19 the lingering effects of a bad infection or the start of a new syndrome?
COVID/Flu Experimental Vaccine Receives Positive R | Newswise
Newswise· 4 days agoA vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According to the drug maker, Moderna the ...
Novavax (NVAX) Seeks FDA Nod for Updated COVID-19 Vaccine
Zacks· 4 days agoFree Report) submitted an application to the FDA, seeking to amend its Emergency Use Authorization (EUA) and update its protein-based COVID-19 vaccine for ...
Kansas AG Kris Kobach accuses Pfizer of misleading vaccine marketing in lawsuit
Kansas Reflector via Yahoo News· 3 days agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
Study sheds light on factors that may predispose some COVID patients to recover more slowly
Medical Xpress· 4 days agoAlthough it's still not clear what causes post-COVID-19 conditions or "long COVID" (symptoms and...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 6 days agoAdministration (FDA) announced Thursday that manufacturers of the COVID vaccines should focus on the KP.2 strain of the JN.1 variant. “Based on the totality of the evidence ...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 11 hours agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-...
NewMediaWire via Yahoo Finance· 3 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...